Empiric Therapy for Intravenous Central Line Infections and Nosocomially-Acquired Acute Bacterial Endocarditis

Critical Care Clinics

Volumn 24, Issue 2, 2008, Pages 293-312

  Bouza, Emilio ^a   Burillo, Almudena ^b   Munoz, Patricia ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b HOSPITAL DE MÓSTOLES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPHOTERICIN B; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; DALBAVANCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; ECHINOCANDIN; FLUCONAZOLE; GENTAMICIN; LINEZOLID; PENICILLIN G; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN;

BACTERIAL ENDOCARDITIS; CATHETER INFECTION; CENTRAL VENOUS CATHETER; HOSPITAL INFECTION; INFECTION PREVENTION; INFECTIOUS COMPLICATION; INTENSIVE CARE UNIT; LOW DRUG DOSE; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; THROMBOPHLEBITIS;

ANTI-BACTERIAL AGENTS; BACTERIA; CATHETERIZATION, CENTRAL VENOUS; CROSS INFECTION; ENDOCARDITIS, BACTERIAL; HUMANS; INTENSIVE CARE UNITS;

EID: 40949089643     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2007.12.002     Document Type: Review

References (128)

1. O'Grady N.P., Alexander M., Dellinger E.P., et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 51 RR-10 (2002) 1-29
2. Alvarez-Lerma F., Palomar M., Olaechea P., et al. National study of control of nosocomial infection in intensive care units. Evolutive report of the years 2003-2005. Med Intensiva 31 1 (2007) 6-17 [in Spanish]
3. Vincent J.L., Bihari D.J., Suter P.M., et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274 8 (1995) 639-644
4. Richards M., Thursky K., and Buising K. Epidemiology, prevalence, and sites of infections in intensive care units. Semin Respir Crit Care Med 24 1 (2003) 3-22
5. Vincent J.L., Sakr Y., Sprung C.L., et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34 2 (2006) 344-353
6. Mermel L.A. Prevention of intravascular catheter-related infections. Ann Intern Med 132 5 (2000) 391-402
7. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32 8 (2004) 470-485
8. Digiovine B., Chenoweth C., Watts C., et al. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 160 3 (1999) 976-981
9. Soufir L., Timsit J.F., Mahe C., et al. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 20 6 (1999) 396-401
10. Rello J., Ochagavia A., Sabanes E., et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med 162 3 Pt 1 (2000) 1027-1030
11. Blot S.I., Depuydt P., Annemans L., et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis 41 11 (2005) 1591-1598
12. Collignon P.J. Intravascular catheter associated sepsis: a common problem. The Australian Study on Intravascular Catheter Associated Sepsis. Med J Aust 161 6 (1994) 374-378
13. Pittet D., Tarara D., and Wenzel R.P. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271 20 (1994) 1598-1601
14. Dimick J.B., Pelz R.K., Consunji R., et al. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 136 2 (2001) 229-234
15. Laupland K.B., Lee H., Gregson D.B., et al. Cost of intensive care unit-acquired bloodstream infections. J Hosp Infect 63 2 (2006) 124-132
16. Hanna R., and Raad II. Diagnosis of catheter-related bloodstream infection. Curr Infect Dis Rep 7 6 (2005) 413-419
17. Safdar N., and Maki D.G. Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Crit Care Med 30 12 (2002) 2632-2635
18. Moyer M.A., Edwards L.D., and Farley L. Comparative culture methods on 101 intravenous catheters. Routine, semiquantitative, and blood cultures. Arch Intern Med 143 1 (1983) 66-69
19. Raad I., Hanna H., and Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 7 10 (2007) 645-657
20. Mermel L.A., Farr B.M., Sherertz R.J., et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32 9 (2001) 1249-1272
21. Safdar N., Fine J.P., and Maki D.G. Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med 142 6 (2005) 451-466
22. Cercenado E., Ena J., Rodriguez-Creixems M., et al. A conservative procedure for the diagnosis of catheter-related infections. Arch Intern Med 150 7 (1990) 1417-1420
23. Fortun J., Perez-Molina J.A., Asensio A., et al. Semiquantitative culture of subcutaneous segment for conservative diagnosis of intravascular catheter-related infection. JPEN J Parenter Enteral Nutr 24 4 (2000) 210-214
24. Bouza E., Munoz P., Burillo A., et al. The challenge of anticipating catheter tip colonization in major heart surgery patients in the intensive care unit: are surface cultures useful?. Crit Care Med 33 9 (2005) 1953-1960
25. Raad I., Hanna H.A., Alakech B., et al. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med 140 1 (2004) 18-25
26. Bouza E., Alvarado N., Alcala L., et al. A randomized and prospective study of 3 procedures for the diagnosis of catheter-related bloodstream infection without catheter withdrawal. Clin Infect Dis 44 6 (2007) 820-826
27. Rijnders B.J., Peetermans W.E., Verwaest C., et al. Watchful waiting versus immediate catheter removal in ICU patients with suspected catheter-related infection: a randomized trial. Intensive Care Med 30 6 (2004) 1073-1080
28. Benezra D., Kiehn T.E., Gold J.W., et al. Prospective study of infections in indwelling central venous catheters using quantitative blood cultures. Am J Med 85 4 (1988) 495-498
29. Bouza E., Alvarado N., Alcala L., et al. A prospective, randomized, and comparative study of 3 different methods for the diagnosis of intravascular catheter colonization. Clin Infect Dis 40 8 (2005) 1096-1100
30. Bouza E., Sousa D., Munoz P., et al. Bloodstream infections: a trial of the impact of different methods of reporting positive blood culture results. Clin Infect Dis 39 8 (2004) 1161-1169
31. Bouza E., Alvarado N., Alcala L., et al. An instant procedure to demonstrate catheter-tip colonization may help clinicians. Diagn Microbiol Infect Dis 56 3 (2006) 255-260
32. Bouza E., Garcia de la Torre M., Erice A., et al. Enterobacter bacteremia. An analysis of 50 episodes. Arch Intern Med 145 6 (1985) 1024-1027
33. Bodey G.P., Elting L.S., and Rodriguez S. Bacteremia caused by Enterobacter: 15 years of experience in a cancer hospital. Rev Infect Dis 13 4 (1991) 550-558
34. Widmer A. Intravenous-related infections. In: Wenzel R.P. (Ed). Prevention and control of nosocomial infections (1993), Williams and Wilkins, Philadelphia 556-579
35. Pittet D., Hulliger S., and Auckenthaler R. Intravascular device-related infections in critically ill patients. J Chemother 7 Suppl 3 (1995) 55-66
36. Jones R.N., Marshall S.A., Pfaller M.A., et al. Nosocomial enterococcal blood stream infections in the SCOPE Program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study Group. Diagn Microbiol Infect Dis 29 2 (1997) 95-102
37. Valles J., Leon C., and Alvarez-Lerma F. Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC). Clin Infect Dis 24 3 (1997) 387-395
38. Munoz P., Bouza E., San Juan R., et al. Clinical-epidemiological characteristics and outcome of patients with catheter-related bloodstream infections in Europe (ESGNI-006 Study). Clin Microbiol Infect 10 9 (2004) 843-845
39. Wisplinghoff H., Bischoff T., Tallent S.M., et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39 3 (2004) 309-317
40. Shorr A.F., Tabak Y.P., Killian A.D., et al. Healthcare-associated bloodstream infection: a distinct entity? Insights from a large U.S. database. Crit Care Med 34 10 (2006) 2588-2595
41. Edmond M.B., Wallace S.E., McClish D.K., et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29 2 (1999) 239-244
42. Sligl W., Taylor G., and Brindley P.G. Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes. Int J Infect Dis 10 4 (2006) 320-325
43. Raad I., Davis S., Khan A., et al. Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia. Infect Control Hosp Epidemiol 13 4 (1992) 215-221
44. Malanoski G.J., Samore M.H., Pefanis A., et al. Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch Intern Med 155 11 (1995) 1161-1166
45. Fowler Jr. V.G., Sanders L.L., Sexton D.J., et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 27 3 (1998) 478-486
46. Cheong I., Samsudin L.M., and Law G.H. Methicillin-resistant Staphylococcus aureus bacteraemia at a tertiary teaching hospital. Br J Clin Pract 50 5 (1996) 237-239
47. Hanna H., Afif C., Alakech B., et al. Central venous catheter-related bacteremia due to gram-negative bacilli: significance of catheter removal in preventing relapse. Infect Control Hosp Epidemiol 25 8 (2004) 646-649
48. Boktour M., Hanna H., Ansari S., et al. Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients. Cancer 106 9 (2006) 1967-1973
49. Nguyen M.H., Peacock Jr. J.E., Tanner D.C., et al. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med 155 22 (1995) 2429-2435
50. Nucci M., Colombo A.L., Silveira F., et al. Risk factors for death in patients with candidemia. Infect Control Hosp Epidemiol 19 11 (1998) 846-850
51. Raad I., Hanna H., Boktour M., et al. Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis 38 8 (2004) 1119-1127
52. Ostrosky-Zeichner L., and Pappas P.G. Invasive candidiasis in the intensive care unit. Crit Care Med 34 3 (2006) 857-863
53. Garcia R., and Raad I. In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections. Eur J Clin Microbiol Infect Dis 15 12 (1996) 933-936
54. Raad I., Bompart F., and Hachem R. Prospective, randomized dose-ranging open phase II pilot study of quinupristin/dalfopristin versus vancomycin in the treatment of catheter-related staphylococcal bacteremia. Eur J Clin Microbiol Infect Dis 18 3 (1999) 199-202
55. Chambers H.F., and Hegde S.S. Combating the growing problem of methicillin-resistant Staphylococcus aureus: do the newer antibiotics represent a better alternative to vancomycin?. Expert Rev Anti Infect Ther 5 3 (2007) 333-335
56. Tack KJ, Wilcox MH, Bouza E, et al. Linezolid vs. vancomycin or oxacillin/dicloxacillin for the treatment of catheter-related bloodstreaminfections (CRBSI). Presented at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago (IL), September 17-20, 2007.
57. Fowler Jr. V.G., Boucher H.W., Corey G.R., et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 355 7 (2006) 653-665
58. Cunha B.A., Hamid N., Kessler H., et al. Daptomycin cure after cefazolin treatment failure of methicillin-sensitive Staphylococcus aureus (MSSA) tricuspid valve acute bacterial endocarditis from a peripherally inserted central catheter (PICC) line. Heart Lung 34 6 (2005) 442-447
59. Raad I., Darouiche R., Vazquez J., et al. Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens. Clin Infect Dis 40 3 (2005) 374-380
60. Slover C.M., Rodvold K.A., and Danziger L.H. Tigecycline: a novel broad-spectrum antimicrobial. Ann Pharmacother 41 6 (2007) 965-972
61. Aslam S., Trautner B.W., Ramanathan V., et al. Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters. Antimicrob Agents Chemother 51 4 (2007) 1556-1558
62. Ghanem G., Adachi J., Han X.Y., et al. Central venous catheter-related Streptomyces septic thrombosis. Infect Control Hosp Epidemiol 28 5 (2007) 599-601
63. Hampton A.A., and Sherertz R.J. Vascular-access infections in hospitalized patients. Surg Clin North Am 68 1 (1988) 57-71
64. Raad I. Intravascular-catheter-related infections. Lancet 351 9106 (1998) 893-898
65. Mortara L.A., and Bayer A.S. Staphylococcus aureus bacteremia and endocarditis. New diagnostic and therapeutic concepts. Infect Dis Clin North Am 7 1 (1993) 53-68
66. Zeylemaker M.M., Jaspers C.A., van Kraaij M.G., et al. Long-term infectious complications and their relation to treatment duration in catheter-related Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 20 6 (2001) 380-384
67. Rosen A.B., Fowler Jr. V.G., Corey G.R., et al. Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. Ann Intern Med 130 10 (1999) 810-820
68. Raad II, and Sabbagh M.F. Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review. Clin Infect Dis 14 1 (1992) 75-82
69. Jernigan J.A., and Farr B.M. Short-course therapy of catheter-related Staphylococcus aureus bacteremia: a meta-analysis. Ann Intern Med 119 4 (1993) 304-311
70. Peacock S.J., Curtis N., Berendt A.R., et al. Outcome following haemodialysis catheter-related Staphylococcus aureus bacteraemia. J Hosp Infect 41 3 (1999) 223-228
71. Rodriguez D., Park B.J., Almirante B., et al. Impact of early central venous catheter removal on outcome in patients with candidaemia. Clin Microbiol Infect 13 8 (2007) 788-793
72. Fernandez-Guerrero M.L., Verdejo C., Azofra J., et al. Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem. Clin Infect Dis 20 1 (1995) 16-23
73. Lamas C.C., and Eykyn S.J. Hospital acquired native valve endocarditis: analysis of 22 cases presenting over 11 years. Heart 79 5 (1998) 442-447
74. Terpenning M.S., Buggy B.P., and Kauffman C.A. Hospital-acquired infective endocarditis. Arch Intern Med 148 7 (1988) 1601-1603
75. Eggimann P., Harbarth S., Constantin M.N., et al. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 355 9218 (2000) 1864-1868
76. Kaech C., Elzi L., Sendi P., et al. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. Clin Microbiol Infect 12 4 (2006) 345-352
77. Garcia-Teresa M.A., Casado-Flores J., Delgado Dominguez M.A., et al. Infectious complications of percutaneous central venous catheterization in pediatric patients: a Spanish multicenter study. Intensive Care Med 33 3 (2007) 466-476
78. Martin-Davila P., Fortun J., Navas E., et al. Nosocomial endocarditis in a tertiary hospital: an increasing trend in native valve cases. Chest 128 2 (2005) 772-779
79. Wenzel R.P. Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis 20 6 (1995) 1531-1534
80. Nasser R.M., Melgar G.R., Longworth D.L., et al. Incidence and risk of developing fungal prosthetic valve endocarditis after nosocomial candidemia. Am J Med 103 1 (1997) 25-32
81. Giamarellou H. Nosocomial cardiac infections. J Hosp Infect 50 2 (2002) 91-105
82. Fernandez-Guerrero M.L., Herrero L., Bellver M., et al. Nosocomial enterococcal endocarditis: a serious hazard for hospitalized patients with enterococcal bacteraemia. J Intern Med 252 6 (2002) 510-515
83. Hsu R.B. Risk factors for nosocomial infective endocarditis in patients with methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 26 7 (2005) 654-657
84. Gouello J.P., Asfar P., Brenet O., et al. Nosocomial endocarditis in the intensive care unit: an analysis of 22 cases. Crit Care Med 28 2 (2000) 377-382
85. Giannitsioti E., Skiadas I., Antoniadou A., et al. Nosocomial vs. community-acquired infective endocarditis in Greece: changing epidemiological profile and mortality risk. Clin Microbiol Infect 13 8 (2007) 763-769
86. Llinares Mondejar P., Nunez Fernandez M., Cordero Lorenzana L., et al. Nosocomial infective endocarditis in patients without heart prosthesis. Rev Clin Esp 197 12 (1997) 814-818 [in Spanish]
87. Fowler Jr. V.G., Olsen M.K., Corey G.R., et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 163 17 (2003) 2066-2072
88. Korbila I.P., Bliziotis I.A., Lawrence K.R., et al. Antibiotic-lock therapy for long-term catheter-related bacteremia: a review of the current evidence. Expert Rev Anti Infect Ther 5 4 (2007) 639-652
89. Raad I., Hanna H., Dvorak T., et al. Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrob Agents Chemother 51 1 (2007) 78-83
90. Chambers S.T., Pithie A., Gallagher K., et al. Treatment of Staphylococcus epidermidis central vascular catheter infection with 70% ethanol locks: efficacy in a sheep model. J Antimicrob Chemother 59 4 (2007) 779-782
91. Elwood R.L., and Spencer S.E. Successful clearance of catheter-related bloodstream infection by antibiotic lock therapy using ampicillin. Ann Pharmacother 40 2 (2006) 347-350
92. Gattuso G., Tomasoni D., Ceruti R., et al. Multiresistant Stenotrophomonas maltophilia tunneled CVC-related sepsis, treated with systemic and lock therapy. J Chemother 16 5 (2004) 494-496
93. Schinabeck M.K., Long L.A., Hossain M.A., et al. Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy. Antimicrob Agents Chemother 48 5 (2004) 1727-1732
94. Curtin J., Cormican M., Fleming G., et al. Linezolid compared with eperezolid, vancomycin, and gentamicin in an in vitro model of antimicrobial lock therapy for Staphylococcus epidermidis central venous catheter-related biofilm infections. Antimicrob Agents Chemother 47 10 (2003) 3145-3148
95. Bailey E., Berry N., and Cheesbrough J.S. Antimicrobial lock therapy for catheter-related bacteraemia among patients on maintenance haemodialysis. J Antimicrob Chemother 50 4 (2002) 615-617
96. Boorgu R., Dubrow A.J., Levin N.W., et al. Adjunctive antibiotic/anticoagulant lock therapy in the treatment of bacteremia associated with the use of a subcutaneously implanted hemodialysis access device. ASAIO J 46 6 (2000) 767-770
97. Easom A. Prophylactic antibiotic lock therapy for hemodialysis catheters. Nephrol Nurs J 27 1 (2000) 75
98. Garcia de la Torre M., and Bouza E. Bacteremia. An old problem. Enferm Infecc Microbiol Clin 9 10 (1991) 594-598
99. Giacometti A., Cirioni O., Ghiselli R., et al. Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. Antimicrob Agents Chemother 49 10 (2005) 4042-4045
100. Castagnola E., Moroni C., Gandullia P., et al. Catheter lock and systemic infusion of linezolid for treatment of persistent Broviac catheter-related staphylococcal bacteremia. Antimicrob Agents Chemother 50 3 (2006) 1120-1121
101. Dannenberg C., Bierbach U., Rothe A., et al. Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with Broviac catheter. J Pediatr Hematol Oncol 25 8 (2003) 616-621
102. Onland W., Shin C.E., Fustar S., et al. Ethanol-lock technique for persistent bacteremia of long-term intravascular devices in pediatric patients. Arch Pediatr Adolesc Med 160 10 (2006) 1049-1053
103. Guedon C., Nouvellon M., Lalaude O., et al. Efficacy of antibiotic-lock technique with teicoplanin in Staphylococcus epidermidis catheter-related sepsis during long-term parenteral nutrition. JPEN J Parenter Enteral Nutr 26 2 (2002) 109-113
104. Capdevila J.A., Segarra A., Planes A.M., et al. Successful treatment of haemodialysis catheter-related sepsis without catheter removal. Nephrol Dial Transplant 8 3 (1993) 231-234
105. Krzywda E.A., Andris D.A., Edmiston Jr. C.E., et al. Treatment of Hickman catheter sepsis using antibiotic lock technique. Infect Control Hosp Epidemiol 16 10 (1995) 596-598
106. Benoit J.L., Carandang G., Sitrin M., et al. Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin Infect Dis 21 5 (1995) 1286-1288
107. Opilla M.T., Kirby D.F., and Edmond M.B. Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr 31 4 (2007) 302-305
108. Al-Hwiesh A.K., and Abdul-Rahman I.S. Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using vancomycin and gentamycin. Saudi J Kidney Dis Transpl 18 2 (2007) 239-247
109. Carratala J. Role of antibiotic prophylaxis for the prevention of intravascular catheter-related infection. Clin Microbiol Infect 7 Suppl 4 (2001) 83-90
110. Biagi E., Arrigo C., Dell'Orto M.G., et al. Mechanical and infective central venous catheter-related complications: a prospective non-randomized study using Hickman and Groshong catheters in children with hematological malignancies. Support Care Cancer 5 3 (1997) 228-233
111. Ackoundou-N'guessan C., Heng A.E., Guenu S., et al. Ethanol lock solution as an adjunct treatment for preventing recurrent catheter-related sepsis-first case report in dialysis setting. Nephrol Dial Transplant 21 11 (2006) 3339-3340
112. Safdar N., and Maki D.G. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin Infect Dis 43 4 (2006) 474-484
113. Bleyer A.J., Mason L., Russell G., et al. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 26 6 (2005) 520-524
114. Raad I., Chatzinikolaou I., Chaiban G., et al. In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother 47 11 (2003) 3580-3585
115. Raad I., Hachem R., Tcholakian R.K., et al. Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits. Antimicrob Agents Chemother 46 2 (2002) 327-332
116. Chatzinikolaou I., Zipf T.F., Hanna H., et al. Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clin Infect Dis 36 1 (2003) 116-119
117. Laird J., Soutar R., and Butcher I. Complications of the ethanol-lock technique in the treatment of central venous catheter sepsis. J Infect 51 4 (2005) 338
118. Metcalf S.C., Chambers S.T., and Pithie A.D. Use of ethanol locks to prevent recurrent central line sepsis. J Infect 49 1 (2004) 20-22
119. Werlin S.L., Lausten T., Jessen S., et al. Treatment of central venous catheter occlusions with ethanol and hydrochloric acid. JPEN J Parenter Enteral Nutr 19 5 (1995) 416-418
120. Pennington C.R., and Pithie A.D. Ethanol lock in the management of catheter occlusion. JPEN J Parenter Enteral Nutr 11 5 (1987) 507-508
121. Jurewitsch B., and Jeejeebhoy K.N. Taurolidine lock: the key to prevention of recurrent catheter-related bloodstream infections. Clin Nutr 24 3 (2005) 462-465
122. Koldehoff M., and Zakrzewski J.L. Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents 24 5 (2004) 491-495
123. Jurewitsch B., Lee T., Park J., et al. Taurolidine 2% as an antimicrobial lock solution for prevention of recurrent catheter-related bloodstream infections. JPEN J Parenter Enteral Nutr 22 4 (1998) 242-244
124. Link H., Bohme A., Cornely O.A., et al. Antimicrobial therapy of unexplained fever in neutropenic patients-guidelines of the infectious diseases working party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society). Ann Hematol 82 Suppl 2 (2003) S105-S117
125. Miller D.L., and O'Grady N.P. Guidelines for the prevention of intravascular catheter-related infections: recommendations relevant to interventional radiology. J Vasc Interv Radiol 14 2 Pt 1 (2003) 133-136
126. Fatkenheuer G., Buchheidt D., Cornely O.A., et al. Central venous catheter (CVC)-related infections in neutropenic patients-guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82 Suppl 2 (2003) S149-S157
127. Protecting 5 million lives from harm. Available at: http://www.ihi.org/IHI/Programs/Campaign.
128. Pronovost P., Needham D., Berenholtz S., et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 355 26 (2006) 2725-2732